Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups - Ferri, Clodoveo; Ursini, Francesco; Gragnani, Laura; Raimondo, Vincenzo; Giuggioli, Dilia; Foti, Rosario; Caminiti, Maurizio; Olivo, Domenico; Cuomo, Giovanna; Visentini, Marcella; Cacciapaglia, Fabio; Pellegrini, Roberta; et al. (Journal of autoimmunity, 2021)
Keywords: 2019-nCoV Vaccine mRNA-1273 - immunology; Antibodies, Neutralizing - blood; Antibodies, Viral - blood; Autoimmune Diseases - blood; Autoimmune Diseases - immunology; Autoimmune systemic diseases; BNT162 Vaccine - immunology; COVID-19 - prevention & control; COVID-19 vaccine; Cryoglobulinemic vasculitis; Female; Humans; Italy; Lupus Erythematosus, Systemic - immunology; Male; Middle Aged; Neutralizing antibodies; Prospective Studies; Rheumatoid arthritis; SARS-CoV-2 - immunology; Scleroderma, Systemic - immunology; Systemic lupus; Systemic sclerosis; Systemic vasculitis; Systemic Vasculitis - immunology; Vaccination; Vaccine Potency; Italy; World Health Organization; Neutralizing antibodies; Systemic lupus; Autoimmune systemic diseases; Neutralizing antibody; Rheumatoid factor; Anti-citrullinated protein antibodies; Systemic lupus erythematosus; Adverse events; Systemic sclerosis; Rheumatoid arthritis; Binding Antibody Units; COVID-19 vaccine; Systemic vasculitis; Cryoglobulinemic vasculitis